DraftKings
DKNG
19.15
-0.60
-3.04%
DraftKings
US · DKNG
#1060 by market cap
Listed 1970
19.15
-0.60
-3.04%
Live - 5344 symbols - heartbeat 387s ago
· 2026-10-08 07:37
Pre-market
19.09
-0.31%
After-hours
19.13
-0.10%
Overnight
19.14
-0.05%
- Market cap
- 9.51B
- P/E (TTM)i
- -54.71
- P/Bi
- 16.70
- EPSi
- -0.01
- Div yieldi
- 0.00%
- 52W posi
- 3%
Reader sentiment
Are you bullish or bearish on DKNG?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 0.81, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +26.99% YoY
Margins
- Gross margin
- 41.25%
- Operating margin
- -0.26%
- Net margin
- -0.07%
Key ratios & quality
- Enterprise valuei
- 10.22B
- Altman Z-Scorei
- 0.81
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 226.28M | 323.41M | 614.53M | 1.30B | 2.24B | 3.67B | 4.77B | 6.05B |
| Gross profit | 177.59M | 219.52M | 267.94M | 501.86M | 756.19M | 1.37B | 1.82B | 2.50B |
| Selling & admin expenses | 221.48M | 310.14M | 942.57M | 1.81B | 1.95B | 1.81B | 2.03B | 2.05B |
| Research & development | 32.89M | 55.93M | 168.63M | 253.66M | 318.25M | 355.16M | 397.11M | 459.91M |
| Operating profit | -76.78M | -146.55M | -843.26M | -1.56B | -1.51B | -789.23M | -609.00M | -15.82M |
| Pretax profit | -76.12M | -142.20M | -1.23B | -1.52B | -1.44B | -791.25M | -593.16M | 7.01M |
| Tax | 105.00K | 58.00K | -622.00K | 8.27M | -67.87M | 10.17M | -86.34M | 4.27M |
| Net profit | -76.22M | -142.73M | -1.23B | -1.52B | -1.38B | -802.14M | -507.29M | 3.71M |
| Basic EPS | 0 | -1 | -4 | -4 | -3 | -2 | -1 | 0 |
| Diluted EPS | -0.20 | -0.77 | -4.03 | -3.78 | -3.16 | -1.73 | -1.05 | -0.01 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 1.41B | 1.51B | 1.14B | 1.99B | 1.65B | 1.44B |
| Gross profit | 565.00M | 657.95M | 359.94M | 914.69M | 696.69M | 551.45M |
| Selling & admin expenses | 508.07M | 398.89M | 517.15M | 629.37M | 567.67M | 491.98M |
| Research & development | 103.26M | 108.42M | 114.68M | 133.56M | 123.18M | 127.65M |
| Operating profit | -46.33M | 150.64M | -271.89M | 151.76M | 5.85M | -68.17M |
| Pretax profit | -39.42M | 169.92M | -270.51M | 147.03M | 22.92M | -71.86M |
| Tax | -5.60M | 11.79M | -12.07M | 10.15M | 6.37M | -1.80M |
| Net profit | -33.86M | 157.94M | -256.79M | 136.43M | 21.07M | -67.61M |
| Basic EPS | 0 | 0 | -1 | 0 | 0 | 0 |
| Diluted EPS | -0.07 | 0.30 | -0.52 | 0.25 | 0.03 | -0.14 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 262.17M | 261.15M | 2.19B | 2.75B | 2.08B | 2.07B | 1.53B | 1.82B |
| Cash & ST investments | 117.91M | 76.53M | 1.82B | 2.15B | 1.31B | 1.27B | 788.29M | 1.13B |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 299.39M | 330.73M | 3.44B | 4.07B | 4.04B | 3.94B | 4.28B | 4.53B |
| Total current liabilities | 195.94M | 255.08M | 554.41M | 929.43M | 1.25B | 1.55B | 1.65B | 1.76B |
| Short-term debt | 3.75M | 6.75M | 12.84M | 12.81M | 4.25M | 11.50M | 10.99M | 9.80M |
| Long-term debt | -- | 68.36M | -- | 1.25B | 1.25B | 1.25B | 1.26B | 1.84B |
| Total liabilities | 484,620,000.00 | 380,305,000.00 | 807,984,000.00 | 2,390,526,000.00 | 2,717,459,000.00 | 3,104,560,000.00 | 3,273,099,000.00 | 3,899,323,000.00 |
| Total equity | -185.23M | -49.58M | 2.63B | 1.68B | 1.32B | 840.31M | 1.01B | 631.46M |
| Retained earnings | -856.05M | -998.78M | -2.23B | -3.75B | -5.13B | -5.93B | -6.44B | -6.44B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 1.80B | 1.79B | 1.95B | 1.82B | 1.58B | 1.58B |
| Cash & ST investments | 1.12B | 1.26B | 1.23B | 1.13B | 999.40M | 983.88M |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 4.52B | 4.47B | 4.62B | 4.53B | 4.31B | 4.28B |
| Total current liabilities | 1.50B | 1.33B | 1.78B | 1.76B | 1.55B | 1.55B |
| Short-term debt | 11.08M | 11.36M | 11.46M | 9.80M | 10.94M | 9.74M |
| Long-term debt | 1.84B | 1.84B | 1.84B | 1.84B | 1.84B | 1.83B |
| Total liabilities | 3,642,898,000.00 | 3,464,674,000.00 | 3,891,949,000.00 | 3,899,323,000.00 | 3,702,484,000.00 | 3,707,951,000.00 |
| Total equity | 872.92M | 1.01B | 732.29M | 631.46M | 605.05M | 569.43M |
| Retained earnings | -6.48B | -6.32B | -6.57B | -6.44B | -6.42B | -6.48B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -45.58M | -46.58M | -194.16M | -419.51M | -625.52M | -1.75M | 417.77M | 662.86M |
| Depreciation & amortization | 7.50M | 13.64M | 77.41M | 121.14M | 169.25M | 201.92M | 270.85M | 275.49M |
| Free cash flow | -72.25M | -88.85M | -240.23M | -517.78M | -729.16M | -115.14M | 296.91M | 508.39M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 0 | 439.00K | 2.06B | -17.83M | -25.52M | -80.05M | -150.96M | -814.04M |
| Ending cash balance | 117.91M | 220.53M | 2.10B | 2.63B | 1.78B | 1.62B | 1.33B | 1.60B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -119.02M | 173.92M | 287.48M | 320.47M | -48.44M | 111.44M |
| Depreciation & amortization | 70.12M | 65.30M | 66.07M | 74.00M | 71.66M | 80.34M |
| Free cash flow | -154.54M | 139.83M | 247.92M | 275.18M | -93.65M | 67.93M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -216.60M | -121.10M | -109.74M | -366.61M | -122.94M | -64.77M |
| Ending cash balance | 1.54B | 1.56B | 1.71B | 1.60B | 1.39B | 1.39B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -- | -- | -70.68 | -69.63 | -91.83 | -74.17 | -54.81 | -0.49 |
| ROA %i | -25.46 | -45.62 | -44.79 | -40.57 | -33.99 | -20.09 | -12.33 | -0.09 |
| ROIC %i | -- | -- | -66.33 | -52.75 | -48.83 | -34.90 | -24.06 | -0.17 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- | -77.38 | -58.40 |
| EBIT margin %i | -33.93 | -45.31 | -137.22 | -120.49 | -67.48 | -21.51 | -12.38 | -0.26 |
| FCF / sales %i | -- | -- | -- | -- | -- | -- | 6.23 | 8.40 |
| Current ratioi | 1.34 | 1.02 | 3.96 | 2.96 | 1.67 | 1.34 | 0.93 | 1.03 |
| Quick ratioi | 0.71 | 0.42 | 3.41 | 2.42 | 1.22 | 1.05 | 0.51 | 0.70 |
| Debt / assetsi | 1.25 | 22.71 | 2.37 | 32.41 | 32.79 | 34.12 | 31.17 | 41.71 |
| LT debt / equityi | -- | -- | 2.61 | 77.79 | 99.83 | 158.82 | 131.02 | 297.73 |
| Interest coveragei | -- | -- | -- | -- | -- | -294.35 | -199.46 | -- |
| Revenue CAGR (3Y) %i | -- | -- | 47.41 | 78.92 | 90.63 | 81.35 | 54.37 | 39.29 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -46.78 | -26.38 | -29.59 | -0.49 | 6.89 | -22.12 |
| ROA %i | -9.59 | -7.01 | -6.01 | -0.09 | 1.15 | -3.99 |
| ROIC %i | -17.17 | -11.70 | -10.58 | -0.17 | 1.92 | -6.46 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -9.64 | -5.39 | -5.28 | -0.26 | 0.58 | -2.93 |
| FCF / sales %i | 5.00 | 7.12 | 9.74 | 8.40 | 9.05 | 7.99 |
| Current ratioi | 1.20 | 1.34 | 1.09 | 1.03 | 1.02 | 1.02 |
| Quick ratioi | 0.85 | 1.05 | 0.76 | 0.70 | 0.70 | 0.69 |
| Debt / assetsi | 42.49 | 42.69 | 41.23 | 41.71 | 44.52 | 44.79 |
| LT debt / equityi | 218.56 | 188.05 | 258.80 | 297.73 | 315.17 | 334.77 |
| Interest coveragei | -65.09 | -15.87 | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Sportsbook is the largest reported line at 61.80% of revenue, across 3 reported segments.
- IGaming follows at 32.01%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Sportsbook61.80%
IGaming32.01%
Other6.20%
Quote time 2026-10-08 07:37:07 · For reference only, not investment advice and not tailored to your situation.